Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cognitive Impairment in Thalassemia and Associated Factors.
Limpawattana P, Juntararuangtong T, Teawtrakul N, Wanitpongpun C, Lanamtieng T, Phiphitaporn P, Chansung K. Limpawattana P, et al. Among authors: lanamtieng t. Dement Geriatr Cogn Disord. 2022;51(2):128-134. doi: 10.1159/000522655. Epub 2022 Mar 23. Dement Geriatr Cogn Disord. 2022. PMID: 35320801
Genetic mutations associated with blood count abnormalities in myeloid neoplasms.
Polprasert C, Kongkiatkamon S, Niparuck P, Rattanathammethee T, Wudhikarn K, Chuncharunee S, Kobbuaklee S, Suksusut A, Lanamtieng T, Lawasut P, Asawapanumas T, Bunworasate U, Rojnuckarin P. Polprasert C, et al. Among authors: lanamtieng t. Hematology. 2022 Dec;27(1):765-771. doi: 10.1080/16078454.2022.2094134. Hematology. 2022. PMID: 35766510
Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations.
Polprasert C, Niparuck P, Rattanathammethee T, Chuncharunee S, Kobbuaklee S, Songserm K, Suksusut A, Trithiphen S, Lanamtieng T, Kongkiatkamon S, Chanswangphuwana C, Lawasut P, Bunworasate U, Rojnuckarin P. Polprasert C, et al. Among authors: lanamtieng t. Clin Lymphoma Myeloma Leuk. 2022 May;22(5):e293-e299. doi: 10.1016/j.clml.2021.10.015. Epub 2021 Nov 2. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34840089
Outcomes of polatuzumab vedotin-containing regimens in real-world setting of relapsed and or refractory diffuse large B-cell lymphoma patients: a matched-control analysis from the Thai Lymphoma Study Group (TLSG).
Rattanathammethee T, Norasetthada L, Bunworasate U, Wudhikarn K, Julamanee J, Noiperm P, Lanamtieng T, Phiphitaporn P, Navinpipat M, Kanya P, Jit-Ueakul D, Wongkhantee S, Suwannathen T, Chaloemwong J, Wong P, Makruasi N, Khuhapinant A, Prayongratana K, Niparuck P, Kanitsap N, Suwanban T, Intragumtornchai T. Rattanathammethee T, et al. Among authors: lanamtieng t. Ann Hematol. 2023 Jul;102(7):1887-1895. doi: 10.1007/s00277-023-05273-8. Epub 2023 May 18. Ann Hematol. 2023. PMID: 37202499